BR112012002698A2 - aneis nitrogenados derivados de acilguanidina - Google Patents
aneis nitrogenados derivados de acilguanidinaInfo
- Publication number
- BR112012002698A2 BR112012002698A2 BR112012002698A BR112012002698A BR112012002698A2 BR 112012002698 A2 BR112012002698 A2 BR 112012002698A2 BR 112012002698 A BR112012002698 A BR 112012002698A BR 112012002698 A BR112012002698 A BR 112012002698A BR 112012002698 A2 BR112012002698 A2 BR 112012002698A2
- Authority
- BR
- Brazil
- Prior art keywords
- acylguanidine
- rings derived
- nitrogen rings
- nitrogen
- derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009183876 | 2009-08-06 | ||
| PCT/JP2010/063240 WO2011016504A1 (ja) | 2009-08-06 | 2010-08-05 | 含窒素環アシルグアニジン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012002698A2 true BR112012002698A2 (pt) | 2019-09-24 |
Family
ID=43544399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012002698A BR112012002698A2 (pt) | 2009-08-06 | 2010-08-05 | aneis nitrogenados derivados de acilguanidina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8853242B2 (pt) |
| EP (1) | EP2463276B1 (pt) |
| JP (1) | JP5692072B2 (pt) |
| KR (1) | KR20120043058A (pt) |
| CN (1) | CN102482220A (pt) |
| AU (1) | AU2010279999A1 (pt) |
| BR (1) | BR112012002698A2 (pt) |
| CA (1) | CA2770409A1 (pt) |
| ES (1) | ES2454769T3 (pt) |
| IL (1) | IL217894A0 (pt) |
| MX (1) | MX2012001625A (pt) |
| RU (1) | RU2012108423A (pt) |
| TW (1) | TW201116281A (pt) |
| WO (1) | WO2011016504A1 (pt) |
| ZA (1) | ZA201200853B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2553237T3 (es) * | 2011-02-02 | 2015-12-07 | Astellas Pharma Inc. | Derivado de tetrahidroisoquinolina |
| JP2014076948A (ja) * | 2011-02-09 | 2014-05-01 | Astellas Pharma Inc | イソキノリンアミド誘導体 |
| JP6113354B2 (ja) * | 2013-05-03 | 2017-04-12 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 神経新生刺激イソキノリン誘導体 |
| CA2974874A1 (en) | 2015-02-11 | 2016-08-18 | Basilea Pharmaceutica International AG | Substituted mono- and polyazanaphthalene derivatives and their use |
| CA2980484C (en) * | 2015-03-24 | 2019-11-26 | Shanghai Yingli Pharmaceutical Co., Ltd | Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereof |
| US10370337B2 (en) | 2015-07-29 | 2019-08-06 | Merck, Sharp & Dohme Corp. | Oxy-cyanoquinolinone PDE9 inhibitors |
| US10376504B2 (en) | 2015-07-29 | 2019-08-13 | Merck, Sharp & Dohme Corp. | Substituted quinolinones as PDE9 inhibitors |
| WO2017019724A1 (en) | 2015-07-29 | 2017-02-02 | Merck Sharp & Dohme Corp. | Phenyl-cyanoquinolinone pde9 inhibitors |
| CN114957114A (zh) * | 2021-02-26 | 2022-08-30 | 冷志 | 一种4-溴-3-氯-7-甲氧基喹啉的合成方法 |
| CN115477610B (zh) * | 2022-09-08 | 2024-03-15 | 河北农业大学 | C-3全氟烷基化4-喹啉酮类化合物的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH039588A (ja) | 1989-06-07 | 1991-01-17 | Nippon Telegr & Teleph Corp <Ntt> | マルチビーム半導体レーザ |
| DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE102004008141A1 (de) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren |
| NZ596107A (en) | 2005-06-24 | 2013-09-27 | Biotron Ltd | Antiviral compounds and methods |
| CA2617473A1 (en) * | 2005-08-08 | 2007-02-15 | Astellas Pharma Inc. | Acylguanidine derivative or salt thereof |
| CA2642610A1 (en) * | 2006-02-20 | 2007-08-30 | Astellas Pharma Inc. | Amide derivative or salt thereof |
| CN101627013A (zh) | 2007-02-07 | 2010-01-13 | 安斯泰来制药有限公司 | 酰基胍衍生物 |
| JP5569857B2 (ja) | 2007-08-10 | 2014-08-13 | アステラス製薬株式会社 | 二環式アシルグアニジン誘導体 |
| MX2010003001A (es) | 2007-09-27 | 2010-04-01 | Hoffmann La Roche | Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a. |
| EP2394987A4 (en) * | 2009-02-09 | 2012-09-05 | Astellas Pharma Inc | ACYLGUANIDINDERIVAT |
| JPWO2010090305A1 (ja) * | 2009-02-09 | 2012-08-09 | アステラス製薬株式会社 | 置換アシルグアニジン誘導体 |
-
2010
- 2010-08-04 TW TW099125923A patent/TW201116281A/zh unknown
- 2010-08-05 CA CA2770409A patent/CA2770409A1/en not_active Abandoned
- 2010-08-05 KR KR1020127005766A patent/KR20120043058A/ko not_active Application Discontinuation
- 2010-08-05 BR BR112012002698A patent/BR112012002698A2/pt not_active IP Right Cessation
- 2010-08-05 WO PCT/JP2010/063240 patent/WO2011016504A1/ja active Application Filing
- 2010-08-05 AU AU2010279999A patent/AU2010279999A1/en not_active Abandoned
- 2010-08-05 MX MX2012001625A patent/MX2012001625A/es active IP Right Grant
- 2010-08-05 JP JP2011525924A patent/JP5692072B2/ja not_active Expired - Fee Related
- 2010-08-05 EP EP10806503.8A patent/EP2463276B1/en active Active
- 2010-08-05 ES ES10806503.8T patent/ES2454769T3/es active Active
- 2010-08-05 US US13/388,872 patent/US8853242B2/en active Active
- 2010-08-05 CN CN2010800350096A patent/CN102482220A/zh active Pending
- 2010-08-05 RU RU2012108423/04A patent/RU2012108423A/ru not_active Application Discontinuation
-
2012
- 2012-02-02 IL IL217894A patent/IL217894A0/en unknown
- 2012-02-03 ZA ZA2012/00853A patent/ZA201200853B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8853242B2 (en) | 2014-10-07 |
| IL217894A0 (en) | 2012-03-29 |
| EP2463276A4 (en) | 2013-02-13 |
| TW201116281A (en) | 2011-05-16 |
| ES2454769T3 (es) | 2014-04-11 |
| EP2463276B1 (en) | 2014-03-12 |
| RU2012108423A (ru) | 2013-09-20 |
| CA2770409A1 (en) | 2011-02-10 |
| JP5692072B2 (ja) | 2015-04-01 |
| EP2463276A1 (en) | 2012-06-13 |
| MX2012001625A (es) | 2012-07-20 |
| US20120142727A1 (en) | 2012-06-07 |
| JPWO2011016504A1 (ja) | 2013-01-10 |
| AU2010279999A1 (en) | 2012-03-01 |
| CN102482220A (zh) | 2012-05-30 |
| ZA201200853B (en) | 2013-05-29 |
| WO2011016504A1 (ja) | 2011-02-10 |
| KR20120043058A (ko) | 2012-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012002698A2 (pt) | aneis nitrogenados derivados de acilguanidina | |
| DK2462134T3 (da) | N1-sulfonyl-5-fluorpyrimidinonderivater | |
| DK2283904T3 (da) | Komponentsystem | |
| BRPI1014920A2 (pt) | luva | |
| BRPI1011134A2 (pt) | turbomáquina. | |
| BRPI1009000A2 (pt) | montagem retentora estojo | |
| DK2401438T3 (da) | Anti-erosionssystem | |
| BR112012025456A2 (pt) | polímeros de eliminação de metais | |
| BRPI1007884A2 (pt) | derivados de actagardina | |
| BR112012030945A2 (pt) | transportador de documentos | |
| BR112013011893A2 (pt) | retentor de cinzel | |
| FR2947857B1 (fr) | Agencement de deshuileur | |
| FI20095671A0 (fi) | Lukitusjärjestely | |
| IT1397151B1 (it) | Apparecchiatura di carotaggio | |
| BR112013007492A2 (pt) | glicodendrímeros de polipropileterimina | |
| DK2299045T3 (da) | Fastgørelsessystem | |
| BR112012009706A2 (pt) | vestuario | |
| FI20096108A0 (fi) | Järjestely | |
| BR112012010525A2 (pt) | novos processos | |
| IT1399653B1 (it) | Apparecchiatura festonatrice. | |
| UY3947Q (es) | Frasco | |
| TH93565B (th) | อุปกรณ์เครื่องเขียน | |
| ES1075975Y (es) | Desactivador de puntos gatillo | |
| TH107809B (th) | แหวนยึดติด | |
| FI20100103A0 (fi) | Purjevene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |